Drilldown: Medicines
Medicines > classes 
:
Sedative-hypnotic or
Selective 5HT2A inverse agonist (with weaker 5HT2C inverse agonism)
& routes:
Oral
:
Sedative-hypnotic or
Selective 5HT2A inverse agonist (with weaker 5HT2C inverse agonism)
& routes:
Oral Use the filters below to narrow your results.
generic:
brand:
classes: (Click arrow to add another value)
mechanism:
Positive allosteric modulator of the GABA<sub>A</sub> receptor at the benzodiazepine binding site; increases frequency of Cl<sup>−</sup> channel opening, producing anxiolytic, sedative, hypnotic, anticonvulsant, and skeletal-muscle relaxant effects. (1) ·
Selective inverse agonist at 5HT2A receptors with weaker activity at 5HT2C. Has no significant dopamine D2 affinity, unique among approved antipsychotics. Inverse agonism (rather than antagonism) reduces constitutive 5HT2A receptor activity below baseline. (1)
uses:
Hallucinations and delusions associated with Parkinson's disease psychosis (PDP). Investigational for psychosis in other dementias and as augmentation for depression. (1) ·
No approved medical problem. Encountered as a designer/research benzodiazepine and, increasingly, as an adulterant in illicit opioid supplies. (1)
starting dose:
preparations:
fda max:
routes: (Click arrow to add another value)
halflife:
bioavailability:
pregnancy:
Showing below up to 2 results in range #1 to #2.